New Combo Immunotherapy Prolongs Survival in Patients With Advanced Kidney Cancer
FRIDAY, April 22, 2022 (HealthDay News) — The use of immunotherapy and/or targeted drugs revolutionized the treatment of many cancers, but some people grow resistant to immunotherapy drugs and relapse as a result. For cases of advanced kidney cancer, a new drug in combination with an existing therapy appears toContinue Reading










